Cite
HARVARD Citation
Agulnik, M. et al. (2017). A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas. Annals of oncology. pp. 121-127. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Agulnik, M. et al. (2017). A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas. Annals of oncology. pp. 121-127. [Online].